4.7 Article

Adverse Events Associated With Treatment for Pan-Susceptible Tuberculosis in San Francisco

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

S. E. Dorman et al.

Summary: The study found that a 4-month rifapentine-based regimen containing moxifloxacin was noninferior to the standard 6-month regimen in the treatment of tuberculosis, supporting the noninferiority hypothesis. This regimen was effective in both the microbiologically eligible population and the assessable population.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Public, Environmental & Occupational Health

Tuberculosis - United States, 2020

Molly Deutsch-Feldman et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Public, Environmental & Occupational Health

Profile and treatment outcomes of elderly patients with tuberculosis in Delhi, India: implications for their management

S. Patra et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2013)

Article Critical Care Medicine

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

D Yee et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)